NEA Management Company’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $184M | Hold |
2,909,956
| – | – | 13.84% | 3 |
|
2025
Q1 | $154M | Hold |
2,909,956
| – | – | 11.87% | 3 |
|
2024
Q4 | $163M | Hold |
2,909,956
| – | – | 9.19% | 4 |
|
2024
Q3 | $152M | Hold |
2,909,956
| – | – | 8.31% | 4 |
|
2024
Q2 | $119M | Hold |
2,909,956
| – | – | 8.99% | 3 |
|
2024
Q1 | $126M | Hold |
2,909,956
| – | – | 7.83% | 3 |
|
2023
Q4 | $134M | Hold |
2,909,956
| – | – | 8.92% | 3 |
|
2023
Q3 | $66.7M | Hold |
2,909,956
| – | – | 5.15% | 7 |
|
2023
Q2 | $48M | Hold |
2,909,956
| – | – | 3.66% | 10 |
|
2023
Q1 | $51.9M | Sell |
2,909,956
-2,000,000
| -41% | -$35.7M | 3.59% | 10 |
|
2022
Q4 | $143M | Sell |
4,909,956
-2,350
| -0% | -$68.4K | 8.03% | 4 |
|
2022
Q3 | $108M | Hold |
4,912,306
| – | – | 5.41% | 5 |
|
2022
Q2 | $20.4M | Hold |
4,912,306
| – | – | 1.05% | 24 |
|
2022
Q1 | $56.6M | Hold |
4,912,306
| – | – | 1.63% | 14 |
|
2021
Q4 | $49M | Hold |
4,912,306
| – | – | 0.99% | 17 |
|
2021
Q3 | $64.2M | Hold |
4,912,306
| – | – | 0.76% | 17 |
|
2021
Q2 | $96.2M | Hold |
4,912,306
| – | – | 1.25% | 12 |
|
2021
Q1 | $104M | Hold |
4,912,306
| – | – | 2.35% | 9 |
|
2020
Q4 | $143M | Hold |
4,912,306
| – | – | 3.77% | 8 |
|
2020
Q3 | $106M | Hold |
4,912,306
| – | – | 4.51% | 7 |
|
2020
Q2 | $110M | Hold |
4,912,306
| – | – | 4.4% | 10 |
|
2020
Q1 | $74.8M | Hold |
4,912,306
| – | – | 3.91% | 10 |
|
2019
Q4 | $113M | Hold |
4,912,306
| – | – | 5.33% | 7 |
|
2019
Q3 | $106M | Hold |
4,912,306
| – | – | 8.78% | 3 |
|
2019
Q2 | $108M | Hold |
4,912,306
| – | – | 7.57% | 3 |
|
2019
Q1 | $135M | Hold |
4,912,306
| – | – | 6.99% | 3 |
|
2018
Q4 | $132M | Hold |
4,912,306
| – | – | 5.24% | 3 |
|
2018
Q3 | $143M | Hold |
4,912,306
| – | – | 6.18% | 4 |
|
2018
Q2 | $154M | Hold |
4,912,306
| – | – | 7.19% | 3 |
|
2018
Q1 | $97.8M | Hold |
4,912,306
| – | – | 4.35% | 7 |
|
2017
Q4 | $143M | Buy |
+4,912,306
| New | +$143M | 5.91% | 3 |
|